Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
05 2020
Historique:
received: 08 10 2019
revised: 27 12 2019
accepted: 03 01 2020
pubmed: 3 3 2020
medline: 18 2 2021
entrez: 2 3 2020
Statut: ppublish

Résumé

There is conflicting evidence regarding the benefits of percutaneous coronary intervention (PCI) in patients with grey zone fractional flow reserve ( We enrolled 104 patients with angina with 1:1 randomisation to PCI or OMT. The artery was interrogated with a Doppler flow/pressure wire. Patients underwent Magnetic Resonance Imaging (MRI) with follow-up at 3 and 12 months. The primary outcome was angina status at 3 months using the Seattle Angina Questionnaire (SAQ). 104 patients (age 60±9 years), 79 (76%) males and 79 (76%) Left Anterior Descending (LAD) stenoses were randomised. Coronary physiology and SAQ were similar. Of 98 patients with stress perfusion MRI data, 17 (17%) had abnormal perfusion (≥2 segments with ≥25% ischaemia or ≥1 segment with ≥50% ischaemia) in the target Non-invasive evidence of major ischaemia is uncommon in patients with NCT02425969.

Identifiants

pubmed: 32114516
pii: heartjnl-2019-316075
doi: 10.1136/heartjnl-2019-316075
pmc: PMC7229900
doi:

Substances chimiques

Cardiovascular Agents 0

Banques de données

ClinicalTrials.gov
['NCT02425969']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

758-764

Subventions

Organisme : British Heart Foundation
ID : PG/14/97/31263
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/186134217
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: There was no industry sponsorship of this trial. CB has undertaken research, consulting and lectures for Abbott Vascular, Opsens and Coroventis based on contracts with The University of Glasgow. KGO has received speaker fees from Abbott Vascular, Boston Scientific and Biosensors. BH has received honoraria from Philips Volcano for consultancy.

Références

JAMA. 2016 Sep 13;316(10):1051-60
pubmed: 27570866
Circ J. 2015;79(1):91-5
pubmed: 25410812
Clin Res Cardiol. 2017 Apr;106(4):259-270
pubmed: 27766423
J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54
pubmed: 25323250
J Am Coll Cardiol. 1995 Feb;25(2):333-41
pubmed: 7829785
J Am Coll Cardiol. 2010 Jun 22;55(25):2816-21
pubmed: 20579537
EuroIntervention. 2017 Jun 2;13(2):e145-e148
pubmed: 28579556
JACC Cardiovasc Imaging. 2014 Nov;7(11):1098-105
pubmed: 25306540
J Am Coll Cardiol. 2007 May 29;49(21):2105-11
pubmed: 17531660
Clin Cardiol. 2010 Feb;33(2):77-83
pubmed: 20186987
Cardiovasc Interv Ther. 2015 Jul;30(3):209-15
pubmed: 25298079
Circulation. 2016 Feb 2;133(5):502-8
pubmed: 26733607
N Engl J Med. 1996 Jun 27;334(26):1703-8
pubmed: 8637515
Eur Heart J. 2018 May 7;39(18):1610-1619
pubmed: 29529177
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92
pubmed: 25173601
J Invasive Cardiol. 2017 Nov;29(11):371-376
pubmed: 28420802
Am J Cardiol. 2014 Jun 1;113(11):1788-93
pubmed: 24837255
Circulation. 2009 Dec 1;120(22):2207-13
pubmed: 19917885
Lancet. 2018 Jan 6;391(10115):31-40
pubmed: 29103656
Heart. 2014 Jun;100(12):951-9
pubmed: 24727867
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):541-8
pubmed: 18307236
N Engl J Med. 2012 Sep 13;367(11):991-1001
pubmed: 22924638
Circulation. 2018 Jan 30;137(5):480-487
pubmed: 29097450

Auteurs

Barry Hennigan (B)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom barrywhennigan@gmail.com.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.
Cardiology Department, The Mater Private Hospital Cork, Cork, Ireland.

Colin Berry (C)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Damien Collison (D)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

David Corcoran (D)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Hany Eteiba (H)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Richard Good (R)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Margaret McEntegart (M)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Stuart Watkins (S)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.

John D McClure (JD)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Kenneth Mangion (K)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Thomas Joseph Ford (TJ)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Mark C Petrie (MC)

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Stuart Hood (S)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Paul Rocchiccioli (P)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Aadil Shaukat (A)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Mitchell Lindsay (M)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Keith G Oldroyd (KG)

Cardiology Department, Golden Jubilee National Hospital, Glasgow, United Kingdom.
BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH